GUIDELINES
RCSSA has developed and maintained this repository of Clinical Practice Guidelines which may be of interest to, and for the benefit of, our members, in an attempt to facilitate access to local and internationally developed and implemented guidelines. RCSSA is not responsible for the contents of guidelines, nor the updating or correctness of guidelines themselves. We endeavour to ensure that all guidelines presented are the most up to date. These guidelines are drawn from the collective of guidelines available from the National authorities as well as specific societies which have generated guidelines for their constituencies.
NATIONAL DEPARTMENT OF HEALTH
- National Health Act 2003
- Draft regulations regarding the general control of human bodies, tissue and organs for transplantation
- White paper on NHI
- NHI Policy 2017
- NHI Bill of 2023
- NHI Act No 20 of 2023
- Department of Health Eastern Cape – Renal Unit Inspection Tool
- COVID-19 environmental health guidelines
- Clinical management of suspected or confirmed COVID-19 disease Version 3 (27 March 2020)
- Coronavirus disease 2019 (COVID-19) caused by a Novel Coronavirus (SARS-CoV-2): Guidelines for case-finding, diagnosis, management and public health response in South Africa
SOUTH AFRICAN NEPHROLOGY SOCIETY (SANS)
- Guidelines for optimal care of patients on chronic dialysis in South Africa 2015
- Guidelines for chronic dialysis in children in South Africa 2015
- Guidelines for the care of patients with acute kidney injury 2015
- Renal palliative and supportive care in South Africa–a consensus statement
SOUTHERN AFRICAN HYPERTENSION SOCIETY (SAHS)
- Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension
- SAHS commentary on the American College of Cardiology/American Heart Association hypertension guidelines 2019
- SAHS hypertension management algorithm for nurse practitioners 2016
- SAHS hypertension management algorithm for medical practitioners 2015
WORLD HEALTH ORGANIZATION (WHO)
SOUTH AFRICAN NATIONAL BLOOD SERVICE (SANBS) & WESTERN PROVINCE BLOOD TRANSFUSION SERVICE (WPBTS)
- Clinical guidelines for the use of blood and blood products in South Africa
- Standards of practice for blood transfusion in South Africa
CRITICAL CARE SOCIETY OF SOUTH AFRICA (CCSA)
- Critical Care Management of Patient Confirmed with COVID-19
- Personal Protective Equipment (PPE) for Critical Care providers during the COVID-19 pandemic
- Principles of airway management in COVID-19
NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES (NICD)
SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY (SAHPRA)
- Complementary medicines – health supplements safety and efficacy
- South African good clinical practice – Clinical trial guidelines
- Clinical guideline
- Guideline for professional information for human medicines (categories A and D)
- Guideline for patient information leaflet for human medicines (categories A and D)
- Electronic submission of clinical trial documents (amendments, bioequivalence studies, responses, notifications and serious adverse events)
- Oversight and monitoring in clinical trials
- Liability insurance for clinical trials
- Guideline for capacity building and transformation in clinical research in South Africa
- Guideline for clinical trial investigators
- Guideline for safety reporting during clinical trials in South Africa
- SAHPGL-CEM-NS-04_v3_Scheduling of substances for prescribing by authorised prescribers other than medical practitioners or dentists
- Guideline for adverse drug reactions (ADR’s) reporting for healthcare professionals
- Guideline for Section 21 access to unregistered medicines
- SAHPRA payment guideline
- Guideline for the importation and exportation of medicines: regulatory compliance unit
- Guidelines for medicine recall/withdrawal and rapid alerts
- Guideline on how to lodge a complaint on medicine and medical devices
- Guidelines for appeals against regulatory decisions
- Guideline on how to apply for a licence to manufacture, import and/or export medicines and scheduled substances
- GWP guideline for the importers and distributors of scheduled substances
- Guideline for medical device vigilance: adverse events reporting for holders of a medical device establishment licence (licensee)/holders of a certificate of registration of a medical device (including an IVD)
- Guideline for classification of medical devices and IVD’s
- Guideline on medical device quality manual
- Guideline for a licence to manufacture, import, export or distribute medical devices and IVD’s
- Guideline on questions and answers: licensing of medical device establishments
- Guideline for completing medical device adverse event form for licence holders (licensee)/holders of a certificate of registration of a medical device (including an IVD)
